Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 2, 2006, Pages 744-747

  Chamilos, Georgios ^a   Lewis, Russell E ^a,b   Kontoyiannis, Dimitrios P ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; FLUCONAZOLE;

ARTICLE; CANDIDA PARAPSILOSIS; DRUG INHIBITION; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA; MICROBIAL SENSITIVITY TESTS; MITOCHONDRIA; OXYGEN CONSUMPTION; PEPTIDES, CYCLIC;

EID: 31944442180     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.2.744-747.2006     Document Type: Article

References (12)

1. Camougrand, N., G. Velnous, and M. Guerin. 1986. Resistance of Candida parapsilosis to drugs. Biol. Cell 58:71-78.
2. Chapman, R. L. 2003. Candida infections in the neonate. Curr. Opin. Pediatr. 15:97-102.
3. Deresinski, S. C., and D. A. Stevens. 2003. Caspofungin. Clin. Infect. Dis. 36:1445-1457.
4. Hernandez, S., J. L. Lopez-Ribot, L. K. Najvar, D. I. McCarthy, R. Bocanegra, and J. R. Graybill. 2004. Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis. Antimicrob. Agents Chemother. 48:1382-1383.
5. Kurtz, M. B., G. Abruzzo, A, Flattery, K, Bartizal, J. A. Marrinan, W. Li, J. Milligan, K. Nollstadt, and C. M, Douglas. 1996. Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infect. Immun. 64:3244-3251.
6. Meletiadis, J., J. W. Mouton, J. F. Meis, B. A. Bouman, J. P. Donnelly, P. E. Verweij, and Eurofung Network, 2001. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 39:3402-3408.
7. Milani, G., W. Jarmuszkiewicz, C. M. Sluse-Goffart, A, Z. Schreiber, A. E. Vercesi, and F, E. Sluse. 2001. Respiratory chain network in mitochondria of Candida parapsilosis: ADP/O appraisal of the multiple electron pathways. FEBS Lett. 508:231-235.
8. Moudgal, V., T. Little, D. Boikov, and J. A. Vazquez. 2005. Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob. Agents Chemother. 49:767-769.
9. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Odds, F. C., M. Motyl, R. Andrade, J. Bille, E. Canton, M. Cuenca-Estrella, A. Davidson, C. Durussel, D. Ellis, E. Foraker, A. W. Fothergill, M. A. Ghannoum, R. A. Giacobbe, M. Gobernado, R. Handke, M. Laverdiere, W. Lee-Yang, W. G. Merz, L. Ostrosky-Zeichner, J. Peman, S. Perea, J. R. Perfect, M. A. Pfaller, L. Proia, J. H. Rex, M. G. Rinaldi, J. L. Rodriguez-Tudela, W. A. Schell, C. Shields, D. A. Sutton, P. E. Verweij, and D. W. Warnock. 2004. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J. Clin. Microbiol. 42:3475-3482.
11. Pappas, G. P., J. H. Rex, J. D. Sobel, S. G. Filler, W. E. Dismukes, and T. J. Walsh. 2004. Guidelines for the treatment of candidiasis. Clin. Infect. Dis. 38:161-189.
12. Pfaller, M. A., D. J. Diekema, R. N. Jones, S. A. Messer, and R. J. Hollis, 2002. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J. Clin. Microbiol. 40:852-856.